A Trial of SHR-1701 With or Without Chemotherapy in Patients With Stage III NSCLC
Status:
Not yet recruiting
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
The study is being conducted to evaluate the efficacy and safety of SHR-1701 with or without
chemotherapy in the treatment of unresectable stage III non-small cell lung cancer